-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The relationship between the evolution of non-alcoholic fatty liver (NAFLD) and chronic kidney disease (CKD) is not yet clear
.
Recently, a research article was published in the Journal of Clinical Endocrinology & Metabolism, an authoritative journal in the field of endocrine and metabolic diseases.
Researchers aimed to assess the relationship between changes in NALFD status and the progression of NAFLD fibrosis and the risk of CKD
.
The researchers conducted a community-based prospective study.
Participants included participants who were 40 years of age or older and had no CKD at baseline in 2010, and were followed up after an average of 4.
4 years
.
NAFLD is diagnosed by ultrasound
Correlation between CKD event risk and NAFLD status change
Among the 4042 participants, compared with non-NAFLD patients, NAFLD was associated with an increased risk of CKD (odds ratio, OR=1.
44, 95% confidence interval [CI] of 1.
003-2.
06; P=0.
048), except for the baseline level , Also adjusted for confounding factors, including the evolution of diabetes , hypertension, and obesity
.
However, there was no significant difference in the risk of CKD between patients with NAFLD elimination and NAFLD persistence
diabetes
It can be seen that NAFLD and fibrosis progression are associated with an increased risk of CKD
.
.
Original source:
Original source:Guangmin Zuo.
New Nonalcoholic Fatty Liver Disease and Fibrosis Progression Associate With the Risk of Incident Chronic Kidney Disease in this message